Bristol-Myers sales up
This article was originally published in Clinica
Executive Summary
In the third quarter, Bristol-Myers Squibb's Convatec division reported an 18% increase for sales of its woundcare products to $57 million, and a 5% increase to $113 million for sales of its ostomy products. Both figures are adjusted for the effects of currency changes and a 1996 disposition.